Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Lien
    Member
    • Dec 2009
    • 47

    SplitNCigarReads exception

    Hi all,

    I'm trying to use the GATK pipeline for analyzing RNA-seq data and to detect variants. According to the GATK Best Practices, I need to allow reads for N cigars.
    So I tried
    java -jar GenomeAnalysisTK.jar -T SplitNCigarReads -R /human_g1k_v37.fasta -I Sample.dedupped.bam -o split.bam -U ALLOW_N_CIGAR_READS

    I started working with version 3.2.2. This works fine for a while, until it comes to a certain line in the BAM-file and spits out this error:
    Bad input: Cannot split this read (might be an empty section between Ns, for example 1N1D1N): 77M54369N2D79N24M

    I looked around on the internet and found that it helps sometimes to add -fixNDN to the command. But this results in the following error:
    Message: Code exception.

    Futhermore, it could be a bug, so I installed the latest version of GATK (3.3.0) but I get the exact same errors (both with and without -fixNDN).

    Any suggestions are most welcomed!
    Thanks,
    Lien
  • linusvanpelt
    Junior Member
    • Apr 2011
    • 5

    #2
    Hi,

    I think I run into this issue the other day, too. Try the latest nightly build of GATK. That fixed it for me. This is a bug that has been fixed if I recall it right.

    Cheers

    Comment

    • Lien
      Member
      • Dec 2009
      • 47

      #3
      Indeed, the latest build fixed it.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 11:41 AM
      0 responses
      8 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      34 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      44 views
      0 reactions
      Last Post SEQadmin2  
      Working...